Lineage Cell Therapeutics, Inc. (LCTX)
1.685
-0.06
(-3.71%)
USD |
NYAM |
Dec 19, 16:00
1.685
0.00 (0.00%)
After-Hours: 16:45
Lineage Cell Therapeutics Total Assets (Quarterly): 89.64M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ocugen, Inc. | 57.60M |
| Belite Bio, Inc. | 282.39M |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
| IGC Pharma, Inc. | 9.743M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 68.84M |
| Shareholders Equity (Quarterly) | 22.04M |
| Debt to Equity Ratio | 0.1189 |
| Current Ratio | 4.504 |
| Net Debt Paydown Yield | 0.02% |